Thursday, May 24th 07:35 PM IST

Organization / Daiichi Sankyo

Daiichi Sankyo.
Daiichi Sankyo
ORGANIZATION
RELATED TO.
Food and Drug Administration

Food and Drug Administration
ORGANIZATION
Skin Cancer

Skin Cancer
DISEASE
Ranbaxy Laboratories

Ranbaxy Laboratories
ORGANIZATION
Bristol-Myers Squibb

Bristol-Myers Squibb
ORGANIZATION
GlaxoSmithKline Inc

GlaxoSmithKline Inc
ORGANIZATION
Genentech, Inc.

Genentech, Inc.
ORGANIZATION
Pfizer Inc.

Pfizer Inc.
ORGANIZATION
Lipitor

Lipitor
DRUG
FIRSTPOST. ARTICLES View all
Ranbaxy Q1 profit jumps on generic Lipitor

Ranbaxy Q1 profit jumps on generic Lipitor

May-09, 2012
Ranbaxy to sell Daiichi\'s anti-hypertension drug in Romania

Ranbaxy to sell Daiichi's anti-hypertension drug in Romania

Apr-19, 2012
Ranbaxy resumes export of generic Lipitor after 4 years

Ranbaxy resumes export of generic Lipitor after 4 years

Apr-02, 2012
Fortis may list in Singapore after poor show in India

Fortis may list in Singapore after poor show in India

Mar-02, 2012
US agencies knock bottom out of Ranbaxy\'s future blockbusters

US agencies knock bottom out of Ranbaxy's future blockbusters

Jan-27, 2012
FROM THE WEB.
Daiichi Sankyo, ArQule complete enrollment in tivantinib plus erlotinib Phase 3 NSCLC trial

Daiichi Sankyo, ArQule complete enrollment in tivantinib plus erlotinib Phase 3 NSCLC trial

May-19,2012
ArQule and Daiichi Sankyo Announce Completion of Patient Recruitment in Phase 3 Clinical Trial of Tivantinib in Non-Small Cell Lung Cancer

ArQule and Daiichi Sankyo Announce Completion of Patient Recruitment in Phase 3 Clinical Trial of Tivantinib in Non-Small Cell Lung Cancer

May-18,2012
World Hypertension Day 2012: Daiichi Sankyo Europe Announces Patient Website Dedicated to Hypertension

World Hypertension Day 2012: Daiichi Sankyo Europe Announces Patient Website Dedicated to Hypertension

May-17,2012
Daiichi Sankyo forms cancer research alliance with National Cancer Center

Daiichi Sankyo forms cancer research alliance with National Cancer Center

May-22,2012
ArQule ready for Phase 3 lung cancer trial

ArQule ready for Phase 3 lung cancer trial

May-18,2012